Back
G1 Therapeutics Stock Price Chart
Sponsored
GTHX
Sponsored
"EarnPhone": The Investment Hidden in Plain Sight
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
46
GTHX
G1 Therapeutics
Last Price:
7.16
Seasonality Move:
-14.81%
7 Day Trial
ALL ACCESS PASS
$
7
The Next Tech Giant in Your Pocket?
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.- Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and GTHX is experiencing slight buying pressure.
G1 Therapeutics Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 7.14 | Buy |
20-day SMA: | 7.13 | Buy |
50-day SMA: | 5.75 | Buy |
200-day SMA: | 4.06 | Buy |
8-day EMA: | 7.14 | Buy |
20-day EMA: | 6.96 | Buy |
50-day EMA: | 6.03 | Buy |
200-day EMA: | 4.37 | Buy |
G1 Therapeutics Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.34 | Buy |
Relative Strength Index (14 RSI): | 84.39 | Buy |
Chaikin Money Flow: | 0 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (7.1 - 7.14) | Buy |
Bollinger Bands (100): | (2.83 - 6.37) | Buy |
G1 Therapeutics Technical Analysis
Sep 5 | Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
05 | 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for G1 Therapeutics Stock
Is G1 Therapeutics Stock a Buy?
- G1 Therapeutics share price is 7.15 while GTHX 8-day simple moving average is 7.14, which is a Buy signal.
- The stock price of GTHX is 7.15 while G1 Therapeutics 20-day SMA is 7.13, which makes it a Buy.
- G1 Therapeutics 50-day simple moving average is 5.75 while GTHX share price is 7.15, making it a Buy technically.
- GTHX stock price is 7.15 and G1 Therapeutics 200-day simple moving average is 4.06, creating a Buy signal.
GTHX Technical Analysis vs Fundamental Analysis
Sell
46
G1 Therapeutics (GTHX)
is a Sell
Is G1 Therapeutics a Buy or a Sell?
-
G1 Therapeutics stock is rated a Sell
The current G1 Therapeutics [GTHX] share price is $7.15. The Score for GTHX is 46, which is 8% below its historic median score of 50, and infers higher risk than normal.
G1 Therapeutics Stock Info
Market Cap:
377.22M
Price in USD:
7.15
Share Volume:
0
G1 Therapeutics 52-Week Range
52-Week High:
7.19
52-Week Low:
1.08
Sell
46
G1 Therapeutics (GTHX)
is a Sell
G1 Therapeutics Share Price Forecast
-
What is the G1 Therapeutics stock price today?
The G1 Therapeutics stock price is 7.15 USD today. -
Will GTHX stock go up or go down?
G1 Therapeutics> share price is forecast to RISE/FALL based on technical indicators -
Is G1 Therapeutics overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, G1 Therapeutics is overvalued.
Is G1 Therapeutics Stock a Buy?
- G1 Therapeutics share price is 7.15 while GTHX 8-day exponential moving average is 7.14, which is a Buy signal.
- The stock price of GTHX is 7.15 while G1 Therapeutics 20-day EMA is 6.96, which makes it a Buy.
- G1 Therapeutics 50-day exponential moving average is 6.03 while GTHX share price is 7.15, making it a Buy technically.
- GTHX stock price is 7.15 and G1 Therapeutics 200-day simple moving average is 4.37, creating a Buy signal.
Fundamental Analysis of G1 Therapeutics
Is G1 Therapeutics a good investment?
- Analysts estimate an earnings increase this quarter of $0.26 per share, an increase next quarter of $0.08 per share, an increase this year of $0.54 per share, and an increase next year of $0.40 per share.
Technical Analysis of G1 Therapeutics
Should I short G1 Therapeutics stock?
- GTHX Moving Average Covergence Divergence (MACD) indicator is 0.34, suggesting G1 Therapeutics is a Buy
- G1 Therapeutics Relative Strength Index (RSI) is 84.39, which suggest G1 Therapeutics is overbought
- The Bollinger Bands (25) for G1 Therapeutics is (7.1 - 7.14), which suggest G1 Therapeutics is a Buy
- The Bollinger Bands (100) for G1 Therapeutics is (2.83 - 6.37), which suggest G1 Therapeutics is a Buy
* G1 Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.